Document 0216 DOCN M95B0216 TI Studies on the intermolecular forces involved in the antibody-antigen interactions, using V3 synthetic peptides and sera from HIV1 seropositive patients. DT 9511 AU Magureanu CG; Diaconu C; Alexandrescu R; Tirdei G; Cernescu C; Stefan S. Nicolau Institute of Virology, Bucharest, Romania. SO Rev Roum Virol. 1994 Jul-Dec;45(3-4):143-57. Unique Identifier : AIDSLINE MED/95345002 AB The nature of physical forces responsible for the antibody-antigen (Ab-Ag) reaction was analyzed in an original system, represented by synthetic peptides derived from the V3 consensus sequences of some HIV1 subtypes gp 120 and HIV1 positive human serum. For locating antigenic determines, flexibility, hydrophilicity and hydrophobicity profiles of the V3 peptides were analysed. The hydrophilicity indicates that V3 apex borders are involved in the first stage of the reaction. The flexibility and hydrophobicity suggest that the apex of the V3 loop (GPGR/Q) is involved in the stabilization of the complex by hydrophobic interactions. Further, we followed up the influence of the dielectric constant and of the pH upon the forces established between Ab and Ag. Modifications in the dielectric constant and pH reveal a significant contribution of electrostatic and van der Waals forces in securing the intermolecular complementarity. D2O produces the highest augmentation of the antibody affinity for the most hydrophilic peptides, while a very slight one was recorded for the most hydrophobic sequence. A high affinity of antibodies for the peptides MN, R and Z was registered at an acid pH, when their His residue was protonated. On the contrary, no influence was recorded in the case of the peptide A, which does not contain any His residue. DE Amino Acid Sequence Antigen-Antibody Reactions/DRUG EFFECTS Deuterium/PHARMACOLOGY Human Hydrogen-Ion Concentration HIV Antibodies/*IMMUNOLOGY HIV Antigens/*IMMUNOLOGY HIV Envelope Protein gp120/*IMMUNOLOGY HIV Seropositivity/*IMMUNOLOGY HIV-1/*IMMUNOLOGY Molecular Sequence Data Peptide Fragments/*IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).